Last Updated : July 24, 2024
Details
Generic Name:
solriamfetol
Project Status:
Not filed
Therapeutic Area:
Excessive daytime sleepiness
Manufacturer:
Axsome Malta Ltd
Brand Name:
Sunosi
Project Line:
Reimbursement Review
Project Number:
NS0039-000
Biosimilar:
No
Submission Type:
Non-submission
Fee Schedule:
N/A
Indications:
The treatment of excessive daytime sleepiness in adult patients with obstructive sleep apnea.
Recommendation Type:
Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission.
Last Updated : July 24, 2024